Hartemann-Heurtier A, Marty L, Ha Van G, Grimaldi A
Service de Diabétologie (prof. Thervet), Hôpital de la Pitié-Salpêtrière, 47-83 bd de l'Hôpital, 75013 Paris.
Diabetes Metab. 2000 May;26(3):219-24.
Antibiotic therapy is not the most important component in diabetic foot ulcer management which should be based on weight bearing avoidance and arterial revascularization. However antibiotic therapy is necessary in presence of extensive deep involvement or systemic signs of infection. Initial antimicrobial treatment depends on bacteria supposed origin. For patients not coming from hospital, the initial choice antibiotic is an amoxicillin/clavulanate agent because it offers optimal coverage for most pathogens involved in those diabetic foot lesions (gram positive cocci, gram negative and anaerobic organisms). For patients at high risk to be infected with nosocomially acquired pathogens, the initial antibiotic therapy must cover methicillin-resistant staphylococci, resistant pseudomonas aeruginosa or enterobacteriae. In all cases, when definitive reliable cultures are reported, initial antibiotic regimens should be revised to narrow the coverage to specific pathogens. In presence of osteomyelitis, a temporary combination of two agents which are known to reach high bone concentrations is necessary, and antibiotic therapy should be continued for at least two months. In other cases, antibiotic treatment duration depends on clinical out come.
抗生素治疗并非糖尿病足溃疡管理中最重要的组成部分,糖尿病足溃疡管理应基于避免负重和动脉血运重建。然而,在存在广泛深部感染或全身感染迹象时,抗生素治疗是必要的。初始抗菌治疗取决于推测的细菌来源。对于非医院获得性感染的患者,初始选择的抗生素是阿莫西林/克拉维酸制剂,因为它能为大多数糖尿病足病变中涉及的病原体(革兰氏阳性球菌、革兰氏阴性菌和厌氧菌)提供最佳覆盖。对于有医院获得性病原体感染高风险的患者,初始抗生素治疗必须覆盖耐甲氧西林葡萄球菌、耐药铜绿假单胞菌或肠杆菌科细菌。在所有情况下,当报告有明确可靠的培养结果时,初始抗生素治疗方案应进行调整,以缩小覆盖范围至特定病原体。在存在骨髓炎的情况下,需要临时联合使用两种已知能在骨中达到高浓度的药物,抗生素治疗应持续至少两个月。在其他情况下,抗生素治疗持续时间取决于临床结果。